2015
DOI: 10.5935/abc.20150063 View full text |Buy / Rent full text
|
|

Abstract: BackgroundCardiac allograft vasculopathy (CAV) is a major limitation for long-term survival of patients undergoing heart transplantation (HT). Some immunosuppressants can reduce the risk of CAV.ObjectivesThe primary objective was to evaluate the variation in the volumetric growth of the intimal layer measured by intracoronary ultrasound (IVUS) after 1 year in patients who received basiliximab compared with that in a control group.MethodsThirteen patients treated at a single center between 2007 and 2009 were an… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
4
0

Publication Types

Select...

Relationship

0
0

Authors

Journals